KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Elanco Animal Health (ELAN) Cash from Investing Activities: 2016-2024

Historic Cash from Investing Activities for Elanco Animal Health (ELAN) over the last 9 years, with Dec 2024 value amounting to $1.2 billion.

  • Elanco Animal Health's Cash from Investing Activities fell 108.12% to -$101.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$305.0 million, marking a year-over-year decrease of 125.14%. This contributed to the annual value of $1.2 billion for FY2024, which is 785.21% up from last year.
  • Per Elanco Animal Health's latest filing, its Cash from Investing Activities stood at $1.2 billion for FY2024, which was up 785.21% from -$169.0 million recorded in FY2023.
  • Over the past 5 years, Elanco Animal Health's Cash from Investing Activities peaked at $1.2 billion during FY2024, and registered a low of -$4.8 billion during FY2020.
  • Its 3-year average for Cash from Investing Activities is $270.0 million, with a median of -$169.0 million in 2023.
  • Its Cash from Investing Activities has fluctuated over the past 5 years, first plummeted by 1,933.62% in 2020, then soared by 785.21% in 2024.
  • Elanco Animal Health's Cash from Investing Activities (MRY) stood at -$4.8 billion in 2020, then surged by 88.91% to -$530.0 million in 2021, then surged by 66.23% to -$179.0 million in 2022, then increased by 5.59% to -$169.0 million in 2023, then surged by 785.21% to $1.2 billion in 2024.
  • Its last three reported values are $1.2 billion in FY2024, -$169.0 million for FY2023, and -$179.0 million during FY2022.